Press release
Multiple Myeloma Market 2026: Gilead Sciences Acquires Arcellx for $7.8B to Control CAR-T Therapy
Multiple Myeloma Market Size 2025
Multiple Myeloma Market reached US$ 22.3 billion in 2024 and is expected to reach US$ 34.58 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2025-2032.
Request Executive Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/multiple-myeloma-market?kb
Multiple Myeloma is a type of blood cancer that originates in plasma cells, a type of white blood cell found in the bone marrow. It leads to abnormal plasma cell growth, which can cause weakened bones, anemia, kidney damage, and immune system dysfunction. Treatment may involve chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation to control disease progression and improve patient outcomes.
United States: Recent Industry Developments
✅ February 2026: Bristol Myers Squibb announced FDA approval for a new CAR-T therapy targeting relapsed/refractory multiple myeloma patients.
✅ January 2026: Janssen introduced a next-generation proteasome inhibitor demonstrating improved efficacy in clinical trials.
✅ December 2025: Amgen expanded its outreach program to enhance access to monoclonal antibody therapies for multiple myeloma patients.
Japan: Recent Industry Developments
✅ February 2026: Ono Pharmaceutical initiated a Phase III clinical trial for an innovative immunotherapy for multiple myeloma.
✅ January 2026: Takeda Pharmaceutical advanced combination therapy regimens for newly diagnosed patients.
✅ December 2025: Eisai launched patient assistance programs to increase availability of targeted therapies across Japan.
Latest Mergers & Acquisitions:
1. Gilead Sciences acquires Arcellx - up to $7.8 billion (2026)
Deal announced: February 23, 2026 - Gilead agreed to acquire Arcellx in a transaction valued at up to $7.8 billion. The deal consists of cash at $115 per share plus a contingent value right (CVR) tied to future sales milestones.
2. Strategic rationale: This acquisition gives Gilead full control of Arcellx's anitocabtagene autoleucel (anito‐cel) CAR‐T therapy, targeting BCMA in relapsed/refractory multiple myeloma - a potentially blockbuster cell therapy candidate with an FDA decision expected by December 2026.
3. Importance: It's one of the largest oncology‐focused M&A deals in early 2026, reflecting consolidation in the CAR‐T space and competition with other cell therapy platforms
Key Players 2026:
Amgen Inc., Sanofi, Novartis AG, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, ONO PHARMACEUTICAL CO., LTD., Pfizer Inc., Karyopharm and Amneal Pharmaceuticals LLC
Growth Forecast Projections 2026:
The Global Multiple Myeloma Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Market Developments 2026:
✅ February 2026: Biopharma companies launched next-generation CAR-T therapies and bispecific antibodies, enhancing treatment efficacy for relapsed and refractory multiple myeloma patients.
✅ January 2026: Advanced proteasome inhibitors and immunomodulatory drugs received expanded approvals, offering improved safety profiles and combination therapy opportunities.
✅ December 2025: Clinical trials demonstrated the effectiveness of novel antibody-drug conjugates, supporting accelerated regulatory pathways and new therapeutic indications.
✅ November 2025: Integration of precision diagnostics, including genomic profiling and MRD (minimal residual disease) testing, enabled personalized treatment strategies and better patient stratification.
✅ October 2025: Healthcare providers increased adoption of oral multiple myeloma therapies and outpatient treatment regimens, improving patient convenience and adherence.
✅ August 2025: Partnerships between biotech firms and hospital networks expanded access programs and clinical trial enrollment for underserved regions.
✅ June 2025: Rising awareness campaigns and patient support initiatives enhanced early diagnosis, timely treatment initiation, and overall patient education.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=multiple-myeloma-market?kb
Major Regional Growth Share 2026:
✅ North America: 42% - Dominates due to advanced healthcare infrastructure, early diagnosis, and high adoption of novel therapies.
✅ Europe: 22% - Supported by expanding access to advanced treatments and clinical trial networks.
✅ Asia-Pacific (including Japan): 20% - Growing adoption of innovative therapies and increasing awareness in Japan, China, and India.
✅ Middle East & Africa: 6% - Emerging market with improved healthcare infrastructure and oncology awareness.
✅ Germany: 4% - Strong R&D focus and access to novel therapeutics.
✅ United Kingdom: 3% - Growing adoption of immunotherapies and precision medicine.
✅ Canada: 2% - Steady growth from advanced cancer care programs.
✅ South Korea: 1% - Adoption of targeted therapies and clinical trials.
✅ Spain: 0.5% - Expansion of multiple myeloma treatment centers.
✅ Other regions: 0.5% - Gradual adoption of therapies and increasing diagnosis rates.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/multiple-myeloma-market?kb
By Type: Smoldering (Indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma
By Treatment: Chemotherapy, Immunotherapy, Radiation, Stem Cell Transplant, Targeted Therapy
By End-User: Hospitals, Cancer Centers, Others
Market Growth Drivers
Rising Prevalence & Aging Population: Cases increasing as populations age, with lifestyle factors like obesity and inactivity contributing.
Explosive Innovation in Therapies: Next-gen treatments (CAR-T, bispecifics, monoclonal antibodies) and combination regimens are improving survival.
Improved Reimbursement & Access: Expanded insurance coverage, subsidies, and faster, patient-friendly formulations are easing treatment access.
Technological & Diagnostic Advances: MRD testing, AI early detection, and personalized medicine enhance precision and treatment success.
Related Reports
CAR-T Cell Therapy Market 2025: https://www.datamintelligence.com/download-sample/car-t-cell-therapy-market?kb
US CAR-T Cell Therapy Market 2025: https://www.datamintelligence.com/download-sample/us-car-t-cell-therapy-market?kb
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Myeloma Market 2026: Gilead Sciences Acquires Arcellx for $7.8B to Control CAR-T Therapy here
News-ID: 4412328 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Non Invasive Prenatal Testing Market to Grow at 13.2% CAGR Through 2033 Amid Adv …
The global Non Invasive Prenatal Testing (NIPT) market is witnessing strong expansion as healthcare systems increasingly prioritize early, accurate, and low risk genetic screening. Rising maternal age, growing incidence of chromosomal abnormalities such as Down syndrome, and a strong preference for safer diagnostic alternatives over invasive procedures are reshaping prenatal care standards worldwide. Across major markets including the United States, Europe, Japan, and China, regulatory clarity and expanding reimbursement frameworks…
U.S. Precision-Guided Munitions (PGMs) Market 2026: Military Advancements and St …
Market Size and Growth
US Precision-Guided Munitions Market reached US$ 6.23 billion in 2023 and is expected to reach US$ 9.82 billion by 2031, growing with a CAGR of 5.85% during the forecast period 2024-2031
Request Executive Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/us-precision-guided-munitions-market?kb
U.S. Precision-Guided Munitions (PGMs) are advanced weapon systems designed to accurately strike targets using guidance systems such as GPS, lasers, or infrared technology, enhancing military precision…
Omega-3 Market Growth 2026 | Industry to hit US$ 4.85 billion by 2032., North Am …
Market Size and Growth
Omega-3 Market reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032.
Request Executive Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/omega-3-market?kb
Omega-3 fatty acids are essential polyunsaturated fats that the body cannot produce on its own. They play a vital role in heart health, brain function, eye health,…
GCC Surface Disinfectant Market Growth 2026 | Regulatory Standards & Innovations …
Market Size and Growth
GCC Surface Disinfectant Market is expected to grow at a CAGR of 8% during the forecast period (2024-2031).
Request Executive Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/gcc-surface-disinfectant-market?kb
United Arab Emirates / GCC: Recent Industry Developments
✅ February 2026: Government and private enterprises in the UAE increased deployment of advanced surface disinfectant solutions in healthcare and public facilities to strengthen hygiene standards.
✅ January 2026: International disinfectant manufacturers launched…
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of…
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal…
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,…
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,…
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of…
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…
